Tag Archive | "pharma"

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

Tags: , , , ,


An interview with Richard Brudnick, Senior VP, Corporate Development, Biogen

De-risking has evolved from literature searches to the cultivation of many wide-ranging relationships throughout the life sciences strata, according to Richard Brudnick, Senior VP, Corporate Development at Biogen. In a recent interview, Brudnick outlined key strategies to accessing innovation and “de-risking” risk through collaboration. Read the full story

Zogenix sells Zohydro franchise to Pernix

Tags: , ,


Pernix Ireland, a wholly owned subsidiary of Pernix Therapeutics has signed a definitive agreement to acquire the Zohydro ER franchise from Zogenix Read the full story

Alexion and Blueprint partner on activated kinase target

Tags: , ,


Blueprint Medicines announced a strategic collaboration with Alexion to discover, develop and commercialize novel drug candidates Read the full story

Acquisition agreement for Shanxi Powerdone

Tags: , ,


Harbin Gloria Pharma pay $380 million to acquire an 85% stake in Shanxi Powerdone, which makes chemical drugs and compound preparations. Read the full story

Alnylam gains $450 million in public offering

Tags: ,


Alnylam Pharmaceuticals has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $450 million Read the full story

Esteve, Purdue Pharma and Mundipharma in pain pact

Tags: ,


Mundipharma Laboratories, Purdue Pharmaceuticals have entered into a global multi programme discovery and development collaboration with Laboratorios Esteve, to bring to market important next generation products for the management of pain Read the full story

Janssen and Vectura partner for anti-inflammatory therapies for asthma/COPD

Tags: , , , ,


Vectura has entered into a global development and licence agreement with Janssen Biotech for the exclusive development of novel anti-inflammatory therapies for the treatment of asthma/COPD Read the full story

Annexon pulls in $34 million series A

Tags: ,


Annexon Bioscience has closed a $34 million Series A-1 to support the development of its lead candidate, ANX005, for the treatment of neurodegenerative and autoimmune disorders Read the full story

Agios in $220 million public offering

Tags: ,


Agios Pharmaceuticals has priced an underwritten public offering of 1,986,455 shares of common stock at a price to the public of $110.75 per share Read the full story

ANI Pharmaceuticals announces $125 million public financing

Tags: ,


ANI Pharmaceuticals announced the pricing of an underwritten public financing offering of $125,000,000 aggregate principal amount of its 3.00% Convertible Senior Notes due 2019 . Read the full story